Ticlopidine administration after stent placement: Frequency of adverse reactions

被引：0

作者：

Russo, RJ ^{[1
]}

Stevens, KM ^{[1
]}

Norman, SL ^{[1
]}

Cloutier, DA ^{[1
]}

Teirstein, PS ^{[1
]}

机构：

[1] SCRIPPS CLIN,LA JOLLA,CA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1997年 / 29卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：48980 / 48980

页数：1

共 50 条

[21] The worst adverse event for an endoscopist after esophageal stent placement: an aortoesophageal fistula [J].

Fugazza, Alessandro ;

Lamonaca, Laura ;

Mercante, Giuseppe ;

Civilini, Efrem ;

Pradella, Andrea ;

Anderloni, Andrea ;

Repici, Alessandro .

ENDOSCOPY, 2022, 54 (02) :E44-E45

[22] Thrombotic stent occlusion and associated major adverse cardiac events beyond the first 2 weeks after coronary stent placement.: Analysis of 3676 patients with a 4-week ticlopidine regimen [J].

Schühlen, H ;

Pache, J ;

Hausleiter, J ;

Mehilli, J ;

Dirschinger, J ;

Kastrati, A ;

Schömig, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :66A-67A

[23] Incidence of thrombotic thrombocytopenic purpura following coronary stent placement and ticlopidine therapy [J].

Feldman, MD ;

Kiss, JE ;

Weinberg, PD ;

Pinevich, AJ ;

Green, D ;

Kwaan, H ;

Bennett, CL .

CIRCULATION, 1998, 98 (17) :573-573

[24] COMPLICATIONS AND REOBSTRUCTION AFTER PLACEMENT OF AN ARTERIAL STENT - FREQUENCY AND METHODS OF TREATMENT [J].

VORWERK, D ;

GUENTHER, RW ;

KEULERS, P ;

BOHNDORF, K ;

WENDT, G .

RADIOLOGY, 1992, 185 :180-180

[25] Adverse reactions after orange essential oil administration to lambs [J].

Silva, Maria Theresa Scheffer Pereira da ;

Oliveira, Bruno Inacio Correa de ;

Aldana, Juan Jose Almazan ;

Carvalho, Matheus Borges de ;

Ollhoff, Rudiger Daniel ;

Sotomaior, Cristina Santos .

VETERINARY PARASITOLOGY- REGIONAL STUDIES AND REPORTS, 2021, 25

[26] Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stent placement: A randomized comparison of cilostazol and ticlopidine [J].

Hoshizaki, H ;

Oshima, S ;

Sekiguchi, M ;

Adachi, H ;

Sakurai, S ;

Toyama, T ;

Naito, S ;

Taniguchi, K .

CIRCULATION, 2001, 104 (17) :55-55

[27] Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement [J].

Kennedy, DJ ;

Colyer, WR ;

Brewster, PS ;

Ankenbrandt, M ;

Burket, MW ;

Nemeth, AS ;

Khuder, SA ;

Thomas, WJ ;

Shapiro, JI ;

Cooper, CJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) :926-935

[28] PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement [J].

Kastrati, A ;

Koch, W ;

Gawaz, M ;

Mehilli, J ;

Böttiger, C ;

Schömig, K ;

von Beckerath, N ;

Schömig, A .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) :84-89

[29] Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine [J].

Dillon, WC ;

Eckert, GJ ;

Dillon, JC ;

Ritchie, ME .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2000, 50 (04) :426-430

[30] Comparison of cilostazol versus ticlopidine therapy after stent implantation [J].

Park, SW ;

Lee, CW ;

Kim, HS ;

Lee, HJ ;

Park, HK ;

Hong, MK ;

Kim, JJ ;

Park, SJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (05) :511-514

← 1 2 3 4 5 →